Article

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease

2023-06-26

Abstract excerpt

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be over, but its variants continue to emerge, and patients with mild symptoms having long COVID is still under investigation. SARS-CoV-2 infection leading to elevated cytokine levels and suppressed immune responses set off cytokine storm, fatal systemic inflammation, tissue damage, and multi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e351beaf-3e8f-5722-abdc-d07feede15be
DOI: 10.1101/2023.06.24.546363

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like proteaseDOI 10.1101/2023.06.24.546363Read

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like proteaseSemantic proximity Read

In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product LibrarySemantic proximity Read

Steroidal lactones from Withania somnifera effectively target Beta, Gamma, Delta and Omicron variants of SARS-CoV-2 and reveal a decreased susceptibility to viral infection and perpetuation: A Polypharmacology ApproachSemantic proximity Read

Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry PerspectiveSemantic proximity Read

Bioinformatics approaches to investigate the phytochemicals of Centella asiatica against the main protease of SARS-CoV-2Semantic proximity Read

Promising natural products against <scp>SARS‐CoV</scp>‐2: Structure, function, and clinical trialsSemantic proximity Read

Phytoconstitutents from Indian medicinal plants show therapeutic potential to combat COVID-19 by bind to SARS CoV-2 Main Protease (Mpro)Semantic proximity Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and LimitationsSemantic proximity Read

Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studySemantic proximity Read

Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational ApproachesSemantic proximity Read

Shortlisting Phytochemicals Exhibiting Inhibitory Activity against Major Proteins of SARS-CoV-2 through Virtual ScreeningSemantic proximity Read